Valerie Odero-Marah to Antineoplastic Agents
This is a "connection" page, showing publications Valerie Odero-Marah has written about Antineoplastic Agents.
Connection Strength
0.291
-
Badal S, Hwang BJ, Nelson A, Frank K, Maitre T, Nwokocha M, Thompson R, Morison B, Haraksingh R, Odero-Marah V, Ragin C. Novel Afro-Caribbean Prostate Cancer Model Reveals Ancestry-Specific Drug Vulnerabilities with Therapeutic Implications for Black Patients. Cancer Res Commun. 2025 10 01; 5(10):1758-1770.
Score: 0.127
-
Muniyan S, Chou YW, Ingersoll MA, Devine A, Morris M, Odero-Marah VA, Khan SA, Chaney WG, Bu XR, Lin MF. Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells. Cancer Lett. 2014 Oct 10; 353(1):59-67.
Score: 0.059
-
Smith BN, Odero-Marah VA. The role of Snail in prostate cancer. Cell Adh Migr. 2012 Sep-Oct; 6(5):433-41.
Score: 0.052
-
Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJ. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol Ther. 2005 Apr; 4(4):400-6.
Score: 0.031
-
White EZ, Pennant NM, Carter JR, Hawsawi O, Odero-Marah V, Hinton CV. Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells. Sci Rep. 2020 07 27; 10(1):12505.
Score: 0.022